[Elsevier] Once-weekly semaglutide...

Gugeww Post time 1 hour(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-06-26 00:06
Reward20points

  • Lim S, Buranapin S, Bao X et al.
    Once-weekly semaglutide 2·4 mg in an Asian population with obesity, defined as BMI ≥25 kg/m2, in South Korea and Thailand (STEP 11): a randomised, double-blind, placebo-controlled, phase 3 trial
    The Lancet Diabetes & Endocrinology, 2025; 13, 838-847


Reply

Use magic Donate Report

All Reply1 Show all posts
acunhalex Post time 29 min. ago | Show all posts

Waiting for confirmation

If the PDF has not been accepted after 72 hours, the system will automatically adopt it.
Reply

Use magic Donate Report

Return to the list